Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve Board meeting to be held for ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Parmax Pharma Ltd has informed BSE that its Board of Directors will meet on August 14, 2025 to consider and approve the un-audited standalone financial results for the quarter ended June 30, 2025 (Q1 FY26). The filing is made under Regulation 29 of the SEBI Listing Regulations. The company has also reminded that the trading window for insiders remains closed until 48 hours after the results are announced.
This is a routine regulatory intimation with no financial numbers disclosed yet. Shareholders should watch the August 14, 2025 announcement for actual Q1 results, which could move the stock depending on performance versus expectations.